Generals lose their current wars by fighting the last one. And regulators in the City of London and on the continent are creating a new crisis because they’re making exactly that mistake.

Italy’s Prysmian SpA agreed to buy electrical parts manufacturer Atkore Inc. in an all-cash deal, extending a US growth drive focused on the data-center buildout.

Current conversations surrounding unconventional weapons — chemical, biological, radiological, and nuclear — have become so fantastical as to be unserious. As the Chinese military fundamentally rethinks biological warfare and Russia continues to use chloropicrin in Ukraine, hypothetical scenarios of

It’s been a sobering stretch for Palantir Technologies Inc. shareholders, who have watched their once high-flying positions lose some 40% of their value since the stock hit a peak in November.

American Bitcoin Corp., the Trump family-backed miner launched last year just before the cryptocurrency tumbled from record highs, posted a third consecutive quarterly loss after a decline in the value of its holdings.

India’s new system to discover end-of-day market prices got off to a confusing start, with traders trying to make sense of a spike in the NSE Nifty 50 Index stemming from the shift.

US stocks rose into the first trading day of the month as attention turned to this week’s heavy slate of earnings reports.

Players like Lamine Yamal and Jude Bellingham are Europe’s rare earths

Why has New York City Mayor Zohran Mamdani become nationally prominent so quickly? Part of it has to do with his bold and controversial policy proposals, his undeniable political skills and his wholehearted embrace of social media. But it can’t hurt that there are so many journalists in New York to

AstraZeneca tops pharma growth rankings while Bristol Myers trails amid merger talks